PORTAGE LEARNING NURS 231: Pathophysiology Module 2 Exam

PORTAGE LEARNING NURS 231: Pathophysiology Module 2 Exam.Question 1 3 / 3 pts True/False: Blood tests for tumor markers are the single best screening tool for cancer. Why or why not? Your Answer: False. Tumor markers, which can be used for establishig prognosis, monitoring treatment and detecting recurrent disease, have limitiations. Under benign situations, tumor markers can still be elevated. Whereas in early stages of malignancy, not elevated. They have a lack of specificity and are then limited in their ability to screen or diagnose accuratley. False, they are elevated in benign conditions, most are not elevated in the early stages of malignancy. Question 2 3 / 3 pts Tissue biopsy is of critical importance in what role? Your Answer: Play a critical role in histologic and cytologic studies for diagnosis of cancers. Diagnosing the correct cancer and histology. Question 3 4 / 4 pts 1. List two signs or symptoms a patient may present with that might indicate a cancer diagnosis: 2. What are two side effects commonly experienced by cancer patients? Your Answer: 1) Bleeding and/or weight loss 2) Anorexia, hair loss 1. Bleeding; sore that doesn’t heal; fluid in the pleural, pericardial, or peritoneal spaces; chest pain, shortness of breath, cough, abdominal discomfort or swelling. Other possible answers can include a mass or lump, pain (need to be specific), fatigue, fevers, weight loss 2. Weight loss, wasting of body fat and muscle tissue, weakness, anorexia, and anemia, fatigue, sleep disturbances Question 4 10 / 10 pts Explain the TNM system: Your Answer: TNM system is a detailed staging system, created by AJCC, is used by cancer facilites. It classifies cancers into stages using 3 tumor components; Tumor, Nodes, Metastasis. T is size and spread of the primary tumor. N is how involved the lymph nodes. M is the extent of metastatic involvement. Classification: Tx, T0, Tis, T1-4 Nx, N0, N1-3 Mx, M0, M1 T is the size and local spread of the primary tumor. N is the involvement of the regional lymph nodes. M is the extent of the metastatic involvement.